Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Pain Called a Disease, Not a Symptom

By HospiMedica staff writers
Posted on 26 Jan 2005
Chronic and recurrent plain is a disease in its own right, not just a symptom, according to two Israeli scientists who published their views in an editorial in the August 17, 2004, issue of Pain Practice.

They based their case on the fact that chronic pain can persist long after its usefulness as an initial alarm to the body has ended, and even after damaged tissue has healed or a precipitating disease has been cured, proving it much more than a symptom. More...
In their article, they point out that chronic pain is "clearly a very widespread condition as several recent studies revealed that 50% of adults surveyed suffer from one or more types of pain or discomfort at any given point in time,” and that "although few people die of pain, many die in pain and even more live in pain.”

The two scientists belong to the European Federation of IASP Chapters (EFIC). IASP stands for International Association for the Study of Pain. An essay on pain by the scientists evolved into a declaration by EFIC that "Pain is a major healthcare problem in Europe. Although acute pain may reasonably be considered a symptom of a disease or injury, chronic and recurrent pain is a specific healthcare problem, a disease in its own right.” They also pointed to data that emphasize the financial implications of pain, since the overall costs are comparable to those of cancer and heart disease.

The scientists involved were David Niv, M.D., director of the Multidisciplinary Center for Pain Medication and Pain Research Laboratory at the Sourasky Medical Center (Tel Aviv, Israel) and Marshall Devor, Ph.D., laboratory head and chairman of the department of cell and animal biology of the Institute of Life Sciences and past director for pain research at the Hebrew University of Jerusalem (Israel).


Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Adjustable Mobile Barrier
M-458
Absorbable Monofilament Mesh
Phasix Mesh
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.